Acute hyperglycemia induced by ketamine/xylazine anesthesia in rats: Mechanisms and implications for preclinical models

Experimental Biology and Medicine

Volumn 230, Issue 10, 2005, Pages 777-784

  Saha, Joy K ^a   Xia, Jinqi ^a   Grondin, Janet M ^a   Engle, Steven K ^a   Jakubowski, Joseph A ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

Acute hyperglycemia; Anesthetic agents; Fasted animals; Fed animals; Glucoregulatory hormones; Hypoinsulinemia; Isoflurane; Ketamine xylazine anesthesia; Pentobarbital sodium

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; ANESTHETIC AGENT; CORTICOSTERONE; CORTICOTROPIN; GLUCAGON; GLUCOSE; GROWTH HORMONE; INSULIN; ISOFLURANE; KETAMINE; PENTOBARBITAL; XYLAZINE; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEEDING; GLUCAGON BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HORMONE RESPONSE; HYPERGLYCEMIA; MALE; NONHUMAN; RAT; RAT STRAIN;

ANIMALIA;

EID: 27644447991     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/153537020523001012     Document Type: Article

References (38)

1. Wright M. Pharmacologic effects of ketamine and its use in veterinary medicine. J Am Vet Med Assoc 180:1462-1471, 1982.
2. Bergman SA. Ketamine: review of its pharmacology and its use in pediatric anesthesia. Anesth Prog 46:10-20, 1999.
3. Lei H., Grinberg O, Nwaigwe CI, Hou Hg, Williams H, Swartz HM. The effects of ketamine-xylazine anesthesia on cerebral blood flow and oxygenation observed using nuclear magnetic resonance perfusion imaging and electron paramagnetic resonance oximetry. Brain Res 913:174-179, 2001.
4. Toso CF, Rodriguez RR, Renauld AR, Marquez AG, Linares LM. Adrenocorticotrophic hormone, cortisol and catecholamine concentrations during insulin hypoglycemia in dogs anaesthetized with thiopentone. Can J Anaesth 40:1084-1091, 1993.
5. Symonds HW, Mallinson CB. The effect of xylazine and xylazine followed by insulin on blood glucose and insulin in the dairy cow. Vet Rec 102:27-29, 1978.
6. Goldfine ID, Arieff AI. Rapid inhibition of basal and glucose stimulated insulin release by xylazine. Endocrinology 105:920-920, 1979.
7. Hsu WH, Hummel SK. Xylazine-induced hyperglycemia in cattle: a possible involvement of α-adrenergic receptors regulating insulin release. Endocrinology 109:825-829, 1981.
8. Muggaberg J, Brockman RP. Effect of adrenergic drugs on glucose and plasma glucagon and insulin response to xylazine in sheep. Res Vet Sci 33:118-120, 1982.
9. Kasuya E, Hodate K, Matsumoto M, Sakaguchi M, Hashizume T, Kanematsu S. The effects of xylazine on plasma concentrations of growth hormone, insulin-like growth factor-1, glucose and insulin in calves. Endocr J 43:145-149, 1996.
10. Kasuya E, Hodate K, Matsumoto M, Sakaguchi M, Hashizume T, Kanematsu S. Effects of atipamezole, an α-adrenergic antagonist, and somatostatin on xylazine-induced growth hormone release in calves. Endocr J 43:551-556, 1996.
11. Ambrisko TD, Hikasa Y. Neurohumoral and metabolic effects of medetomidine compared with xylazine in beagle dogs. Can J Vet Res 66:42-49, 2002.
12. Kawai N, Keep RF, Betz AL. Hyperglycemia and the vascular effects of cerebral ischemia. Stroke 28:149-154, 1997.
13. Helmer KS, Cui Y, Chang L, Dewan A, Mercer DW. Effect of ketamine/xylazine on expression of tumor necrosis factor-α inducible nitric oxide synthase, and cyclo-oxygenase-2 in rat gastric mucosa. Shock 20:63-69, 2003.
14. Saha JK, Xia J, Grondin J, Engle SK, Jakubowski JA. Anesthesia-induced acute hyperglycemia in rodent. FASEB J 18:A578, 2004.
15. Nauck MA, Walberg J, Vethacke A, El-Quaghlidi A, Senkal M, Holst JJ, Galwitz JB, Schmidt WT, Schmiegel W. Blood glucose control in healthy subject and patients receiving intravenous glucose infusion or total parenteral nutrition using glucagon-like-peptide-1. Regul Peptides 118:89-97, 2004.
16. Feldberg W, Symonds HW. Hyperglycemic effect of xylazine. J Vet Pharmacol Ther 3:197-202, 1980.
17. Geary N, Langhansm W, Sharrer E. Metabolic concomitants of glucagon-induced suppression of feeding in the rat. Am J Physiol 241:R330-R335, 1981.
18. Hampshire J, Altszuler N. Clonidine or xylazine as provocative test for growth hormone secretion in the dog. Am J Vet Res 42:1073-1076, 1981.
19. 1-imidazoline and α-2 adrenergic receptors in the modulation of glucose metabolism in the spontaneously hypertensive obese rat model of metabolic syndrome X. J Pharmacol Exp Ther 306:646-657, 2003.
20. Saito M, Saitoh T, Inoue S. Alpha-2 adrenergic modulation of pancreatic glucagon secretion in rats. Physiol Behav 51:1165-1171, 1992.
21. Brockman RP. Effect of xylazine on plasma glucose, glucagon, and insulin concentrations in sheep. Res Vet Sci 30:383-384, 1981.
22. Ambrisko TD, Hikasa Y. The antagonistic effects of atipamezole and yohimbine on stress-related neurohormonal and metabolic responses induced by medetomidine in dogs. Can J Vet Res 67:64-67, 2002.
23. Hsu WH, Hembrough FB. Intravenous glucose tolerance test in cats: influenced by acetylpromazine, ketamine, morphine, thiopental, and xylazine. Am J Vet Res 43:2060-2061, 1982.
24. Lehmann R, Wagner JL, Fernandez LA, Bourgoignie JJ, Rocordi C, Alejandro R, Kenyon NS. Effects of ketamine sedation on glucose clearance, insulin secretion and counter regulatory hormone production in baboons (Papio hamadryas). J Med Primatol 26:312-321, 1997.
25. Heath DF, Frayn KN, Rose JG. Glucose turnover in the post-absorptive rat and the effects of halothane anesthesia. Biochem J 162:653-657, 1977.
26. Horber FF, Krayer S, Rehder K, Haymond MW. Anesthesia with halothane and nitrous oxide alters protein and amino acid metabolism in dogs. Anesthesiology 69:319-326, 1988.
27. Bailey CJ, Atkins TW, Matty AJ. Blood glucose and plasma insulin levels during prolonged pentobarbitone anesthesia in the rat. Endocrinol Exp 9:177-185, 1975.
28. Johansen O, Vaaler S, Jorde R, Reikeras O. Increased plasma levels after Hypnorm anesthesia, but not after pentobarbital anesthesia in rats. Lab Anim 28:244-248, 1994.
29. Illera JC, Gil AG, Illera M. The effects of different anesthetic treatments on the adreno-cortical functions and glucose levels in NZW rabbits. J Physiol Biochem 56:329-336, 2000.
30. Penicaud L, Ferre P, Kande J, Leturque A, Issad T, Girard J. Effect of anesthesia on glucose production and utilization in rats. Am J Physiol 252:E365-E369, 1987.
31. Clark PW, Jenkins AB, Kraegen EW. Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. Am J Physiol 258:E701-E707, 1990.
32. Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycemia and increased risk after myocardial infarction in patients without diabetes: a systematic overview. Lancet 355:773-778, 2000.
33. Davies MJ, Lawrence IG. DIGAMI (diabetes mellitus, insulin glucose infusion in acute myocardial infarction): theory and practice. Diabetes Obes Metab 4:289-295, 2001.
34. Scott JF, Robinson GM, French JM, O'Connell JE, Alberti KGMM, Gray CS. Blood pressure response to glucose potassium insulin therapy in patients with acute stroke with mild to moderate hyperglycemia. J Neurol Neurosurg Psychiatry 70:401-404, 2001.
35. Bruno A, Williams LS, Kent TA. How important is hyperglycemia during acute brain infarction? Neurologist 10:195-200, 2004.
36. Van Den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vladdelaers D, Ferdinande C, Lauwers P, Bouillon R. Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359-1367, 2001.
37. Marfella R, D'amico M, Di Filippo C, Piegari E, Nappo F, Esposito K, Berrino L, Rossi F, Giugliano D. Myocardial infarction in diabetic rats: role of hyperglycemia on infarct size and early expression of hypoxiainducible factor. Diabetologia 45:1172-1181, 2002.
38. Shiomi T, Tsutsui H, Ikeuchi M, Matsusaka H, Hayashidani S, Suematsu N, Wen J, Kubota T. Streptozotocin-induced hyperglycemia exacerbates left ventricular remodeling and failure after experimental myocardial infarction. J Am Coll Cardiol 42:165-172, 2003.